Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 23
171
Views
4
CrossRef citations to date
0
Altmetric
Short Communications

New sesquiterpene glycoside ester with antiprotozoal activity from the flowers of Calendula officinalis L

ORCID Icon, &
Pages 5250-5254 | Received 30 Nov 2019, Accepted 19 Mar 2020, Published online: 01 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Reham M. Samra, Galal T. Maatooq & Ahmed A. Zaki. (2022) A new antiprotozoal compound from Calendula officinalis. Natural Product Research 36:22, pages 5747-5752.
Read now

Articles from other publishers (3)

Daniil N. Olennikov & Nina I. Kashchenko. (2022) Marigold Metabolites: Diversity and Separation Methods of Calendula Genus Phytochemicals from 1891 to 2022. Molecules 27:23, pages 8626.
Crossref
Siddig Ibrahim Abdelwahab, Manal Mohamed Elhassan Taha, Sarah Mohamed Elhassan Taha & Abdulrahman Ahmed Alsayegh. (2022) Fifty-year of Global Research in Calendula Officinalis L. (1971−2021): A Bibliometric Study. Clinical Complementary Medicine and Pharmacology 2:4, pages 100059.
Crossref
Raquel Durão, Cátia Ramalhete, Ana Margarida Madureira, Eduarda Mendes & Noélia Duarte. (2022) Plant Terpenoids as Hit Compounds against Trypanosomiasis. Pharmaceuticals 15:3, pages 340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.